Entera Bio ENTX Q1 2026 Earnings Narrowing Losses as Cash Burn Remains in Focus Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 Xometry Inc XMTR Q1 2026 Earnings Strong EPS Beat Amidst Limited Revenue Disclosure GROV Q1 2026 Earnings Significant EPS Beat Surprises Market SBGI Q1 2026 Earnings EPS Surges Past Estimates with 13155 Surprise CHTR Q1 2026 Earnings EPS Misses Estimates as Broadband Subscriber Trends Pressure Results